94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Lauren E. Fritsch1Jing Ju2Erwin Kristobal Gudenschwager Basso3Eman Soliman3Swagatika Paul4Jiang Chen2†Alexandra M. Kaloss3Elizabeth A. Kowalski3Taylor C. Tuhy5Rachana Deven Somaiya1Xia Wang3Irving Coy Allen3Michelle H. Theus3,5*
Alicia M. Pickrell5*- 1Translational Biology, Medicine, and Health Graduate Program, Virginia Polytechnic Institute and State University, Roanoke, VA, United States
- 2Molecular and Cellular Biology Graduate Program, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States
- 3Department of Biomedical Sciences and Pathobiology, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States
- 4Biomedical and Veterinary Sciences Graduate Program, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States
- 5School of Neuroscience, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States
A Corrigendum on
Type I Interferon Response Is Mediated by NLRX1-cGAS-STING Signaling in Brain Injury
by Fritsch, L. E., Ju, J., Gudenschwager Basso, E. K., Soliman, E., Paul, S., Chen, J., Kaloss, A. M., Kowalski, E. A., Tuhy, T. C., Somaiya, R. D., Wang, X., Allen, I. C., Theus, M. H., and Pickrell, A. M. (2022). Front. Mol. Neurosci. 15:852243. doi: 10.3389/fnmol.2022.852243
In the published article, there was an error in Table 1 as published. The forward and reverse sequences for the rows “IL-6” and “MCP1” were incorrectly entered as “CTA GCT CAG GCT CGT CAG TTC.” The corrected Table 1 and its caption appear below.
TABLE 1
Table 1. qPCR primers used in experiments.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: brain injury, inflammation, STING, cGAS, innate immunity
Citation: Fritsch LE, Ju J, Basso EKG, Soliman E, Paul S, Chen J, Kaloss AM, Kowalski EA, Tuhy TC, Somaiya RD, Wang X, Allen IC, Theus MH and Pickrell AM (2022) Corrigendum: Type I Interferon Response Is Mediated by NLRX1-cGAS-STING Signaling in Brain Injury. Front. Mol. Neurosci. 15:965564. doi: 10.3389/fnmol.2022.965564
Received: 09 June 2022; Accepted: 10 June 2022;
Published: 29 June 2022.
Edited and reviewed by: Andrei Surguchov, University of Kansas Medical Center, United States
Copyright © 2022 Fritsch, Ju, Basso, Soliman, Paul, Chen, Kaloss, Kowalski, Tuhy, Somaiya, Wang, Allen, Theus and Pickrell. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alicia M. Pickrell, YWxpY2lhLnBpY2tyZWxsQHZ0LmVkdQ==; Michelle H. Theus, bXRoZXVzQHZ0LmVkdQ==
†Present address: Jiang Chen, Sorrento Therapeutics, Inc., San Diego, CA, United States